15 years of revenue, profit, cash flow and balance-sheet history through FY2025,
from SEC filings — with a computed, factual read of the trend.
Updated Overview →
Growth & profitability
Revenue has declined 0.9% per year over the past 5 years.
Operating margin has contracted, at -30.5% in the latest year.
Financial health
Operating income covered interest expense -54.9× in the latest year.
The company is unprofitable; at its current free-cash-flow burn it has roughly 1.2 years of cash runway.
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key annual figures
FY
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
2025
$27M
-$8M
36.3%
-30.5%
-$10M
—
$12M
2024
$23M
-$5M
43.6%
-20.0%
$3M
—
$5M
2023
$25M
-$5M
40.6%
-17.6%
-$864661
—
$1M
2022
$25M
-$2M
44.3%
-9.4%
-$2M
—
$2M
2021
$24M
$4M
47.5%
-5.0%
$373582
—
$4M
2020
$28M
-$6M
38.3%
-21.1%
$1M
—
$1M
2019
$33M
-$5M
37.3%
-13.9%
-$5M
—
$877676
2018
$36M
-$6M
37.9%
-15.4%
-$5M
—
$272552
2017
—
$47436
—
—
-$1M
—
$2M
2016
—
-$1M
—
—
-$3M
—
$4M
2015
—
-$3M
—
—
-$5M
—
$5M
2014
—
-$4M
—
—
-$5M
—
$1M
2013
—
-$3M
—
—
-$4M
—
$8M
2012
—
-$2M
—
—
-$3M
—
$8M
2011
—
-$2M
—
—
-$3M
—
$2M
Revenue & net income
RevenueNet income
Margins (gross / operating / net)
GrossOperatingNet
Free cash flow (CFO − capex, quarterly)
Free cash flow
Cash vs total debt
CashTotal debt
Cash flow: operating / investing / financing
OperatingInvestingFinancing
Key quarterly figures
Quarter
Revenue
Net income
Gross M
Op M
FCF
Total debt
Cash
Mar '26
$6M
-$2M
40.9%
-33.7%
-$3M
—
$9M
Dec '25
$5M
-$4M
36.8%
-77.8%
-$3M
—
$12M
Sep '25
$7M
-$2M
30.4%
-29.2%
-$4M
—
$15M
Jun '25
$7M
-$1M
33.8%
-19.4%
-$3M
—
$2M
Mar '25
$7M
-$659922
44.3%
-8.2%
-$1M
—
$4M
Dec '24
$6M
-$1M
45.0%
-18.7%
$4M
—
$5M
Sep '24
$6M
-$930408
44.1%
-15.5%
-$489588
—
$1M
Jun '24
$5M
-$2M
44.0%
-31.2%
-$609603
—
$841913
Mar '24
$6M
-$1M
41.6%
-17.0%
$143264
—
$2M
Dec '23
$6M
-$2M
39.8%
-30.8%
$187317
—
$1M
Sep '23
$7M
-$481573
41.1%
-5.2%
-$1M
—
$646161
Jun '23
$7M
-$780110
42.0%
-11.6%
$418935
—
$2M
Mar '23
$5M
-$1M
38.9%
-26.9%
-$284866
—
$2M
Dec '22
$5M
-$1M
52.5%
-30.9%
-$946178
—
$2M
Sep '22
$7M
-$256712
43.7%
-3.2%
$67581
—
$3M
Jun '22
$6M
-$856218
42.1%
-12.7%
-$3M
—
$3M
Mar '22
$7M
$89409
41.6%
1.1%
$2M
—
$5M
Dec '21
$7M
$62965
48.1%
1.9%
$285746
—
$4M
Sep '21
$5M
$1M
46.7%
-18.1%
$238989
—
$3M
Jun '21
$6M
$399631
46.3%
-5.0%
-$504827
—
$3M
Valuation over time
How the market has priced TGEN against its own fundamentals since 2025-05 —
each month-end's share price set against the most recent annual filing, so the multiple moves
as price runs ahead of (or behind) earnings. Split-adjusted.
The price-to-sales ratio has fallen from 6.2× (May '25) to 5.7× (Jun '26).
Price / sales (P/S)
P/S
Frequently asked questions
Is TGEN growing its revenue and profit?
Over the past 5 years, TECOGEN INC.'s revenue has declined 0.9% per year. These are computed facts, not advice.
How much debt does TGEN have?
As of FY2025, TECOGEN INC. reported — of total debt against $12M of cash; operating income covered interest expense -54.9×.
What is TGEN's profit margin?
In FY2025, gross margin was 36.3%, operating margin -30.5%, and net margin -30.5%.
Where does this data come from?
All figures are extracted from the company’s SEC EDGAR/XBRL filings — 10-K annual reports and 10-Q quarterly reports (use the Annual / Quarterly toggle). Quarterly figures are derived from the as-filed statements (year-to-date amounts are differenced into discrete quarters). Growth rates and ratios are computed by tradmap; nothing here is investment advice.
Source: SEC EDGAR / XBRL (10-K + 10-Q filings) · prices EOD (Databento), corporate-action-adjusted ·
growth rates, valuation multiples & ratios computed by tradmap. Valuation uses each month-end price
against the latest annual filing. Informational only — not investment advice.